Cargando…

Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances

Enterovirus B (EV-B)-related diseases, which can be life threatening in high-risk populations, have been recognized as a serious health problem, but their clinical treatment is largely supportive, and no selective antivirals are available on the market. As their clinical relevance has become more se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tammaro, Chiara, Guida, Michela, Appetecchia, Federico, Biava, Mariangela, Consalvi, Sara, Poce, Giovanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966857/ https://www.ncbi.nlm.nih.gov/pubmed/37259352 http://dx.doi.org/10.3390/ph16020203

Ejemplares similares

SAR Analysis of Small Molecules Interfering with Energy-Metabolism in Mycobacterium tuberculosis
por: Appetecchia, Federico, et al.
Publicado: (2020)

A Novel Class of Dual-Acting DCH-CORMs Counteracts Oxidative Stress-Induced Inflammation in Human Primary Tenocytes
por: Appetecchia, Federico, et al.
Publicado: (2021)

Antiviral Mechanisms of N-Phenyl Benzamides on Coxsackie Virus A9
por: Laajala, Mira, et al.
Publicado: (2023)

Chocolate Consumers and Lymphocyte-to-Monocyte Ratio: A Working Hypothesis from a Preliminary Report of a Pilot Study in Celiac Subjects
por: Raguzzini, Anna, et al.
Publicado: (2019)

Direct-acting antivirals and host-targeting strategies to combat enterovirus infections
por: Bauer, Lisa, et al.
Publicado: (2017)

Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment
por: Hanieh, Patrizia Nadia, et al.
Publicado: (2022)

Recent developments in antiviral agents against enterovirus 71 infection
por: Tan, Chee Wah, et al.
Publicado: (2014)

The enteroviruses: recent advances.
por: Wenner, H. A.
Publicado: (1982)

Inhibition of Human Coronaviruses by Combinations of Host-Targeted and Direct-Acting Antivirals
por: de León, Patricia, et al.
Publicado: (2023)

Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus
por: Kanda, Tatsuo, et al.
Publicado: (2015)

HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents
por: Angeletti, Andrea, et al.
Publicado: (2019)

Antivirals and vaccines for Enterovirus A71
por: Lin, Jing-Yi, et al.
Publicado: (2019)

Enterovirus 71 antagonizes the inhibition of the host intrinsic antiviral factor A3G
por: Li, Zhaolong, et al.
Publicado: (2018)

Influenza Antiviral Subversion: Now the Host Is in on the Act
por: Yepsen, Erin N., et al.
Publicado: (2021)

Recent Information on Pan-Genotypic Direct-Acting Antiviral Agents for HCV in Chronic Kidney Disease
por: Fabrizi, Fabrizio, et al.
Publicado: (2022)

Strategies to develop antivirals against enterovirus 71
por: Kuo, Rei-Lin, et al.
Publicado: (2013)

The Antiviral Effect of Baicalin on Enterovirus 71 In Vitro
por: Li, Xiang, et al.
Publicado: (2015)

Antiviral activity of micafungin against enterovirus 71
por: Kim, Chonsaeng, et al.
Publicado: (2016)

Antivirals blocking entry of enteroviruses and therapeutic potential
por: Anasir, Mohd Ishtiaq, et al.
Publicado: (2021)

HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals
por: Rice, Donald P., et al.
Publicado: (2016)

Antiviral Effect of Matrine against Human Enterovirus 71
por: Yang, Yajun, et al.
Publicado: (2012)

Developments towards antiviral therapies against enterovirus 71
por: Wu, Kan X., et al.
Publicado: (2010)

Antiviral Effect of Bovine Lactoferrin against Enterovirus E
por: Wróbel, Małgorzata, et al.
Publicado: (2022)

Enterovirus A71 antivirals: Past, present, and future
por: Wang, Jun, et al.
Publicado: (2022)

Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis
por: Karayiannis, Peter
Publicado: (2012)

Direct-acting antiviral retreatment patterns for hepatitis C
por: Hasan, Shaquib Al, et al.
Publicado: (2022)

A Systematic Review of Direct-Acting Antivirals for Hepatitis C in Advanced CKD
por: Balk, Ethan M., et al.
Publicado: (2022)

Direct‐acting antivirals ability to clear intestinal HCV‐RNA in liver transplant patients
por: Pietrosi, Giada, et al.
Publicado: (2020)

Repurposing Antifungals for Host-Directed Antiviral Therapy?
por: Schloer, Sebastian, et al.
Publicado: (2022)

Antiviral and Inflammatory Cellular Signaling Associated with Enterovirus 71 Infection
por: Jin, Yuefei, et al.
Publicado: (2018)

Enteroviruses: Classification, diseases they cause, and approaches to development of antiviral drugs
por: Nikonov, O. S., et al.
Publicado: (2018)

Antiviral Properties of Pennisetum purpureum Extract against Coronaviruses and Enteroviruses
por: Chen, Yi-Ning, et al.
Publicado: (2022)

Psychiatric treatment considerations with direct acting antivirals in hepatitis C
por: Sockalingam, Sanjeev, et al.
Publicado: (2013)

Mechanisms of Hepatitis C Viral Resistance to Direct Acting Antivirals
por: Ahmed, Asma, et al.
Publicado: (2015)

Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
por: Wisløff, Torbjørn, et al.
Publicado: (2018)

Assessing the Safety of Direct-Acting Antiviral Agents for Hepatitis C
por: McGlynn, Elizabeth A., et al.
Publicado: (2019)

Direct-acting antivirals and visceral leishmaniasis: a case report
por: Colomba, Claudia, et al.
Publicado: (2019)

Drug-drug interactions with direct-acting antivirals — less is more
por: Wong, Grace Lai-Hung
Publicado: (2021)

Current and Future Direct-Acting Antivirals Against COVID-19
por: Chan, Shiu-Wan
Publicado: (2020)

The ‘Viennese epidemic’ of acute HCV in the era of direct‐acting antivirals
por: Chromy, David, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5r51t168ot98bfrmipcbppu3el